Gilead Sciences, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
690.00
6,859.00
5,814.00
8,278.00
1,669.00
5,160.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-880.00
-2,303.00
-1,763.00
489.00
-1,638.00
-798.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
10,828.00
8,006.00
9,072.00
11,384.00
8,168.00
9,144.00
Cash Flow from Investing Activities
-3,449.00
-2,265.00
-2,466.00
-3,131.00
-14,615.00
-7,817.00
Cash Flow from Financing Activities
-3,433.00
-5,125.00
-6,469.00
-8,877.00
770.00
-7,634.00
Net Cash Inflow / Outflow
3,906.00
673.00
74.00
-659.00
-5,634.00
-6,309.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-40.00
57.00
-63.00
-35.00
43.00
-2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Gilead Sciences, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
690
4609
-3,919.00
-85.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-880
2365
-3,245.00
-137.21%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
10828
11490
-662.00
-5.76%
Cash Flow from Investing Activities
-3449
-1046
-2,403.00
-229.73%
Cash Flow from Financing Activities
-3433
-9415
5,982.00
63.54%
Net Cash Inflow / Outflow
3906
1029
2,877.00
279.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-40
0
-40.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 35.25% vs -11.75% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
10,828.00
8,006.00
35.25%






